Latest papers

Still searching for a new therapeutic strategy for acute myocardial infarction.

[Patients with cardiovascular risk. SH/fT study: mortality rate reduced by a fourth].

Capecitabine cardiac toxicity presenting as effort angina: a case report.

The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-beta1/Smad2 expression.

Combined rho kinase and renin-angiotensin system inhibition: a new therapeutic perspective for renal and cardiovascular remodeling.

The utility of cardiovascular drugs in the treatment of cerebrovascular disease.

Primate models for cardiovascular drug research and development.

Agenesis of the renal segment of inferior vena cava associated with venous stasis.

Circulating monocyte subsets and cardiovascular risk factors in coronary artery disease.

Dual modulation of nitric oxide production in the heart during ischaemia/reperfusion injury and inflammation.

Inappropriate sinus tachycardia - successful treatment with ivabradine.

Asymptomatic carotid artery stenosis—Medical therapy alone versus medical therapy plus carotid endarterectomy or stenting

Stress cardiomyopathy and arrhythmic storm in a 14-year-old boy.

PAI-1-derived peptide EEIIMD prevents impairment of cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia.

Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR.

Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.

Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps my angina. Do you have any suggestions for my heart since I no longer make testosterone, which I understand helps protect men's hearts and arteries.

[Acute poisonings: general management and main causes].

Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.

Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.